A multi-omics study identifies causal genes and biological subtypes of long COVID, revealing new therapeutic targets for ...
Multi-omics describes the integration of multiple high-throughput screening technologies based on genomics, proteomics, transcriptomics, single-cell transcriptomics, metabolomics, and more, which all ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
Understanding why cancer cells rely on specific genes is critical for designing effective targeted therapies. A new study ...
Acute myeloid leukaemia (AML) is mainly characterized by an increase in the number of myeloid cells in the bone marrow and a decrease in mature cells, accounting for 28% of leukaemia cases, with a ...
Efficacy of third-line and later (3L+) therapies post poly (ADP-ribose) polymerase inhibitor (PARPi) exposure in recurrent platinum-sensitive ovarian cancer (PSOC): A pooled clinical trial database ...
A groundbreaking review in Biological Diversity proposes a proactive, AI - integrated approach to stop biological invasions ...
Nearly 50 new cancer therapies are approved every year. While this positive trend is a huge benefit for patients, Altuna Akalin, PhD, head of the bioinformatics and omics data science technology ...
AI and large-scale datasets will unlock new biology learning via spatial omics. Provided byOwkin 37 trillion. That is the number or cells that form a human being. How they all work together to sustain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback